PubRank

Heidi L Weiss

Author PubWeight™ 59.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma. Nat Med 2008 11.49
2 Neoadjuvant trastuzumab induces apoptosis in primary breast cancers. J Clin Oncol 2005 3.62
3 mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways. Cancer Res 2011 3.12
4 Use of error grid analysis to evaluate acceptability of a point of care prothrombin time meter. Clin Chim Acta 2009 2.12
5 Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. J Control Release 2013 1.77
6 Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res 2007 1.58
7 Lobular neoplasia on core-needle biopsy--clinical significance. Cancer 2004 1.57
8 Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 2004 1.54
9 Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes. Cancer 2010 1.52
10 Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients. Blood 2008 1.52
11 Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates. Clin Cancer Res 2004 1.42
12 Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer. J Am Coll Surg 2010 1.41
13 Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. Cancer Res 2012 1.31
14 VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis. Int J Cancer 2011 1.27
15 Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer. J Biol Chem 2011 1.23
16 Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antivir Ther 2003 1.18
17 Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 2006 1.18
18 Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis 2002 1.07
19 Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer. Breast Cancer Res 2015 1.04
20 Clinical applications for change-point analysis of herpes zoster pain. J Pain Symptom Manage 2002 1.02
21 Sorafenib enhances the therapeutic efficacy of rapamycin in colorectal cancers harboring oncogenic KRAS and PIK3CA. Carcinogenesis 2012 1.01
22 Deregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors. Carcinogenesis 2013 1.01
23 Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment. Mol Ther 2008 1.00
24 mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON. Am J Physiol Cell Physiol 2011 0.96
25 Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage. Clin Cancer Res 2004 0.94
26 Acceptability of urine screening for Neisseria gonorrheae and Chlamydia trachomatis in adolescents at an urban emergency department. Sex Transm Dis 2003 0.92
27 Delivery of RNA nanoparticles into colorectal cancer metastases following systemic administration. ACS Nano 2015 0.92
28 Using dendritic cell maturation and IL-12 producing capacity as markers of function: a cautionary tale. J Immunother 2008 0.91
29 PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport. Mol Endocrinol 2012 0.90
30 A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level. Clin Infect Dis 2003 0.90
31 Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study. J Clin Oncol 2007 0.89
32 The impact of a family history of breast cancer on screening practices and attitudes in low-income, rural, African American women. J Womens Health (Larchmt) 2003 0.88
33 A survey of the barriers associated with academic-based cancer research commercialization. PLoS One 2013 0.87
34 NFATc1 regulation of TRAIL expression in human intestinal cells. PLoS One 2011 0.86
35 In vivo investigation of hybrid Paclitaxel nanocrystals with dual fluorescent probes for cancer theranostics. Pharm Res 2013 0.85
36 Nuclear factor of activated T-cell c3 inhibition of mammalian target of rapamycin signaling through induction of regulated in development and DNA damage response 1 in human intestinal cells. Mol Biol Cell 2012 0.83
37 Neurotensin, a novel target of Wnt/β-catenin pathway, promotes growth of neuroendocrine tumor cells. Int J Cancer 2014 0.82
38 The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON. Anticancer Res 2011 0.81
39 The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause. J Support Oncol 2006 0.81
40 Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease. J Exp Ther Oncol 2010 0.80
41 Transforming growth factor-alpha: a surrogate endpoint biomarker? J Am Coll Surg 2002 0.80
42 p53 and erbB-2 are not associated in matched cases of primary and metastatic ovarian carcinomas. Dis Markers 2004 0.76
43 Assessment of risk factors for stillbirth among pregnant women in Jamaica. J Obstet Gynaecol 2004 0.75
44 Effects of body weight gain reduction resulting from chemopreventive agent treatment on mammary gland morphology. Nutr Cancer 2002 0.75